Potential Mechanism of Protective Effect of Liver X Receptor Activation on A-Galcer-induced Liver Injury in Mice

LIU Yuan,BIAN Zhaolian,HAN Xiaofeng,WANG Qixia,QIU Dekai,MA Xiong
DOI: https://doi.org/10.3969/j.issn.1008-7125.2011.06.002
2011-01-01
Abstract:Background: Liver X receptor(LXR) is a member of nuclear receptors superfamily that plays central role in the transcriptional control of genes involved in lipid metabolism.Meanwhile,LXR also has immune regulatory and anti-inflammatory effects.Aims: To investigate the potential mechanism underlying the protective effect of LXR activation on α-GalCer-induced liver injury in mice.Methods: Fifteen C57BL/6J mice were randomly divided into normal control group,α-GalCer model group and LXR treatment group.α-GalCer was administered intraperitoneally to induce liver injury in α-GalCer model group and LXR treatment group,and LXR agonist T0901317 was given intraperitoneally to mice in LXR treatment group for 7 days before α-GalCer administration.Mice were sacrificed 6 hours after α-GalCer administration.Histopathological examination was performed on liver sections,and the serum levels of ALT and AST were measured.The hepatic interleukin-6(IL-6) expression was assessed by immunohistochemical staining.The activation of PI3K/Akt/NF-κB signal pathway in liver was detected by Western blotting.The hepatic tumor necrosis factor-α(TNF-α) and inducible nitric oxide synthase(iNOS) mRNA expressions were determined by real-time RT-PCR.Results: Compared with normal control group,significant liver injury could be observed histopathologically in α-GalCer model group,with increased serum transaminase levels and upregulated hepatic IL-6,TNF-α and iNOS expressions,and PI3K/Akt/NF-κB signal pathway in liver was activated.In LXR treatment group the α-GalCer-induced liver injury was attenuated,serum transaminase levels were decreased,expressions of hepatic inflammatory mediators were reduced,and the activation of PI3K/Akt/NF-κB signal pathway in liver was inhibited.Conclusions: Activation of LXR can attenuate α-GalCer-induced liver injury in mice by its immune regulatory and anti-inflammatory effects.The potential mechanism might be related to inhibiting the activation of PI3K/Akt/NF-κB signal pathway.
What problem does this paper attempt to address?